Global Nicotine Gums and Lozenges Market Growth 2025-2031

August 2025 | 89 pages | ID: G54337619700EN
LP Information

Abstracts

The global Nicotine Gums and Lozenges market size is predicted to grow from US$ 900 million in 2025 to US$ 1316 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Nicotine gums and lozenges are over-the-counter nicotine replacement therapy (NRT) products designed to help individuals quit smoking by reducing withdrawal symptoms and nicotine cravings. These products deliver controlled doses of nicotine to the bloodstream through oral absorption, offering a safer alternative to smoking by avoiding harmful tobacco-related toxins. Nicotine gums are chewed to release nicotine gradually, while lozenges dissolve in the mouth, providing a discreet and convenient option for smokers seeking to manage their addiction. Both forms are widely recommended as part of smoking cessation programs and have been shown to significantly increase the chances of quitting successfully when used correctly.

The market for nicotine gums and lozenges is driven by the increasing global awareness of the health risks associated with smoking and the growing demand for effective smoking cessation aids. Government initiatives, public health campaigns, and stricter regulations on tobacco products have encouraged more individuals to quit smoking, fueling the adoption of nicotine replacement therapies. Additionally, rising healthcare costs and the shift toward preventive healthcare further support market growth. The convenience, accessibility, and non-invasive nature of gums and lozenges make them popular choices among users, while ongoing product innovations, such as flavored and sugar-free options, continue to expand their appeal across diverse consumer segments.

LP Information, Inc. (LPI) ' newest research report, the “Nicotine Gums and Lozenges Industry Forecast” looks at past sales and reviews total world Nicotine Gums and Lozenges sales in 2024, providing a comprehensive analysis by region and market sector of projected Nicotine Gums and Lozenges sales for 2025 through 2031. With Nicotine Gums and Lozenges sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotine Gums and Lozenges industry.

This Insight Report provides a comprehensive analysis of the global Nicotine Gums and Lozenges landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotine Gums and Lozenges portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotine Gums and Lozenges market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotine Gums and Lozenges and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotine Gums and Lozenges.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotine Gums and Lozenges market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 2 mg/piece
• 4 mg/piece
• Other

Segmentation by Application:

• Withdrawal Clinics
• Medical Practice
• Individual Smokers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis
• Perrigo Company
• Pfizer
• Fertin Pharma
• Johnson & Johnson
• Cipla
• Alkalon
• GSK
• Reynolds American
• Dr. Reddy's Laboratories

Key Questions Addressed in this Report
What is the 10-year outlook for the global Nicotine Gums and Lozenges market?
What factors are driving Nicotine Gums and Lozenges market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nicotine Gums and Lozenges market opportunities vary by end market size?
How does Nicotine Gums and Lozenges break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nicotine Gums and Lozenges Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Nicotine Gums and Lozenges by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Nicotine Gums and Lozenges by Country/Region, 2020, 2024 & 2031
2.2 Nicotine Gums and Lozenges Segment by Type
  2.2.1 2 mg/piece
  2.2.2 4 mg/piece
  2.2.3 Other
2.3 Nicotine Gums and Lozenges Sales by Type
  2.3.1 Global Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
  2.3.2 Global Nicotine Gums and Lozenges Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Nicotine Gums and Lozenges Sale Price by Type (2020-2025)
2.4 Nicotine Gums and Lozenges Segment by Application
  2.4.1 Withdrawal Clinics
  2.4.2 Medical Practice
  2.4.3 Individual Smokers
  2.4.4 Others
2.5 Nicotine Gums and Lozenges Sales by Application
  2.5.1 Global Nicotine Gums and Lozenges Sale Market Share by Application (2020-2025)
  2.5.2 Global Nicotine Gums and Lozenges Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Nicotine Gums and Lozenges Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Nicotine Gums and Lozenges Breakdown Data by Company
  3.1.1 Global Nicotine Gums and Lozenges Annual Sales by Company (2020-2025)
  3.1.2 Global Nicotine Gums and Lozenges Sales Market Share by Company (2020-2025)
3.2 Global Nicotine Gums and Lozenges Annual Revenue by Company (2020-2025)
  3.2.1 Global Nicotine Gums and Lozenges Revenue by Company (2020-2025)
  3.2.2 Global Nicotine Gums and Lozenges Revenue Market Share by Company (2020-2025)
3.3 Global Nicotine Gums and Lozenges Sale Price by Company
3.4 Key Manufacturers Nicotine Gums and Lozenges Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nicotine Gums and Lozenges Product Location Distribution
  3.4.2 Players Nicotine Gums and Lozenges Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NICOTINE GUMS AND LOZENGES BY GEOGRAPHIC REGION

4.1 World Historic Nicotine Gums and Lozenges Market Size by Geographic Region (2020-2025)
  4.1.1 Global Nicotine Gums and Lozenges Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Nicotine Gums and Lozenges Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nicotine Gums and Lozenges Market Size by Country/Region (2020-2025)
  4.2.1 Global Nicotine Gums and Lozenges Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Nicotine Gums and Lozenges Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nicotine Gums and Lozenges Sales Growth
4.4 APAC Nicotine Gums and Lozenges Sales Growth
4.5 Europe Nicotine Gums and Lozenges Sales Growth
4.6 Middle East & Africa Nicotine Gums and Lozenges Sales Growth

5 AMERICAS

5.1 Americas Nicotine Gums and Lozenges Sales by Country
  5.1.1 Americas Nicotine Gums and Lozenges Sales by Country (2020-2025)
  5.1.2 Americas Nicotine Gums and Lozenges Revenue by Country (2020-2025)
5.2 Americas Nicotine Gums and Lozenges Sales by Type (2020-2025)
5.3 Americas Nicotine Gums and Lozenges Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nicotine Gums and Lozenges Sales by Region
  6.1.1 APAC Nicotine Gums and Lozenges Sales by Region (2020-2025)
  6.1.2 APAC Nicotine Gums and Lozenges Revenue by Region (2020-2025)
6.2 APAC Nicotine Gums and Lozenges Sales by Type (2020-2025)
6.3 APAC Nicotine Gums and Lozenges Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nicotine Gums and Lozenges by Country
  7.1.1 Europe Nicotine Gums and Lozenges Sales by Country (2020-2025)
  7.1.2 Europe Nicotine Gums and Lozenges Revenue by Country (2020-2025)
7.2 Europe Nicotine Gums and Lozenges Sales by Type (2020-2025)
7.3 Europe Nicotine Gums and Lozenges Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nicotine Gums and Lozenges by Country
  8.1.1 Middle East & Africa Nicotine Gums and Lozenges Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Nicotine Gums and Lozenges Revenue by Country (2020-2025)
8.2 Middle East & Africa Nicotine Gums and Lozenges Sales by Type (2020-2025)
8.3 Middle East & Africa Nicotine Gums and Lozenges Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotine Gums and Lozenges
10.3 Manufacturing Process Analysis of Nicotine Gums and Lozenges
10.4 Industry Chain Structure of Nicotine Gums and Lozenges

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nicotine Gums and Lozenges Distributors
11.3 Nicotine Gums and Lozenges Customer

12 WORLD FORECAST REVIEW FOR NICOTINE GUMS AND LOZENGES BY GEOGRAPHIC REGION

12.1 Global Nicotine Gums and Lozenges Market Size Forecast by Region
  12.1.1 Global Nicotine Gums and Lozenges Forecast by Region (2026-2031)
  12.1.2 Global Nicotine Gums and Lozenges Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nicotine Gums and Lozenges Forecast by Type (2026-2031)
12.7 Global Nicotine Gums and Lozenges Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.1.3 Novartis Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Perrigo Company
  13.2.1 Perrigo Company Company Information
  13.2.2 Perrigo Company Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.2.3 Perrigo Company Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Perrigo Company Main Business Overview
  13.2.5 Perrigo Company Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.3.3 Pfizer Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Fertin Pharma
  13.4.1 Fertin Pharma Company Information
  13.4.2 Fertin Pharma Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.4.3 Fertin Pharma Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Fertin Pharma Main Business Overview
  13.4.5 Fertin Pharma Latest Developments
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Information
  13.5.2 Johnson & Johnson Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.5.3 Johnson & Johnson Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Johnson & Johnson Main Business Overview
  13.5.5 Johnson & Johnson Latest Developments
13.6 Cipla
  13.6.1 Cipla Company Information
  13.6.2 Cipla Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.6.3 Cipla Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Cipla Main Business Overview
  13.6.5 Cipla Latest Developments
13.7 Alkalon
  13.7.1 Alkalon Company Information
  13.7.2 Alkalon Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.7.3 Alkalon Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Alkalon Main Business Overview
  13.7.5 Alkalon Latest Developments
13.8 GSK
  13.8.1 GSK Company Information
  13.8.2 GSK Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.8.3 GSK Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 GSK Main Business Overview
  13.8.5 GSK Latest Developments
13.9 Reynolds American
  13.9.1 Reynolds American Company Information
  13.9.2 Reynolds American Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.9.3 Reynolds American Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Reynolds American Main Business Overview
  13.9.5 Reynolds American Latest Developments
13.10 Dr. Reddy's Laboratories
  13.10.1 Dr. Reddy's Laboratories Company Information
  13.10.2 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolios and Specifications
  13.10.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Dr. Reddy's Laboratories Main Business Overview
  13.10.5 Dr. Reddy's Laboratories Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nicotine Gums and Lozenges Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nicotine Gums and Lozenges Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 2 mg/piece
Table 4. Major Players of 4 mg/piece
Table 5. Major Players of Other
Table 6. Global Nicotine Gums and Lozenges Sales by Type (2020-2025) & (K Units)
Table 7. Global Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
Table 8. Global Nicotine Gums and Lozenges Revenue by Type (2020-2025) & ($ million)
Table 9. Global Nicotine Gums and Lozenges Revenue Market Share by Type (2020-2025)
Table 10. Global Nicotine Gums and Lozenges Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global Nicotine Gums and Lozenges Sale by Application (2020-2025) & (K Units)
Table 12. Global Nicotine Gums and Lozenges Sale Market Share by Application (2020-2025)
Table 13. Global Nicotine Gums and Lozenges Revenue by Application (2020-2025) & ($ million)
Table 14. Global Nicotine Gums and Lozenges Revenue Market Share by Application (2020-2025)
Table 15. Global Nicotine Gums and Lozenges Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Nicotine Gums and Lozenges Sales by Company (2020-2025) & (K Units)
Table 17. Global Nicotine Gums and Lozenges Sales Market Share by Company (2020-2025)
Table 18. Global Nicotine Gums and Lozenges Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Nicotine Gums and Lozenges Revenue Market Share by Company (2020-2025)
Table 20. Global Nicotine Gums and Lozenges Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Nicotine Gums and Lozenges Producing Area Distribution and Sales Area
Table 22. Players Nicotine Gums and Lozenges Products Offered
Table 23. Nicotine Gums and Lozenges Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Nicotine Gums and Lozenges Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Nicotine Gums and Lozenges Sales Market Share Geographic Region (2020-2025)
Table 28. Global Nicotine Gums and Lozenges Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Nicotine Gums and Lozenges Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Nicotine Gums and Lozenges Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Nicotine Gums and Lozenges Sales Market Share by Country/Region (2020-2025)
Table 32. Global Nicotine Gums and Lozenges Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Nicotine Gums and Lozenges Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Nicotine Gums and Lozenges Sales by Country (2020-2025) & (K Units)
Table 35. Americas Nicotine Gums and Lozenges Sales Market Share by Country (2020-2025)
Table 36. Americas Nicotine Gums and Lozenges Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Nicotine Gums and Lozenges Sales by Type (2020-2025) & (K Units)
Table 38. Americas Nicotine Gums and Lozenges Sales by Application (2020-2025) & (K Units)
Table 39. APAC Nicotine Gums and Lozenges Sales by Region (2020-2025) & (K Units)
Table 40. APAC Nicotine Gums and Lozenges Sales Market Share by Region (2020-2025)
Table 41. APAC Nicotine Gums and Lozenges Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Nicotine Gums and Lozenges Sales by Type (2020-2025) & (K Units)
Table 43. APAC Nicotine Gums and Lozenges Sales by Application (2020-2025) & (K Units)
Table 44. Europe Nicotine Gums and Lozenges Sales by Country (2020-2025) & (K Units)
Table 45. Europe Nicotine Gums and Lozenges Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Nicotine Gums and Lozenges Sales by Type (2020-2025) & (K Units)
Table 47. Europe Nicotine Gums and Lozenges Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Nicotine Gums and Lozenges Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Nicotine Gums and Lozenges Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Nicotine Gums and Lozenges Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Nicotine Gums and Lozenges Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Nicotine Gums and Lozenges
Table 53. Key Market Challenges & Risks of Nicotine Gums and Lozenges
Table 54. Key Industry Trends of Nicotine Gums and Lozenges
Table 55. Nicotine Gums and Lozenges Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Nicotine Gums and Lozenges Distributors List
Table 58. Nicotine Gums and Lozenges Customer List
Table 59. Global Nicotine Gums and Lozenges Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Nicotine Gums and Lozenges Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Nicotine Gums and Lozenges Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Nicotine Gums and Lozenges Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Nicotine Gums and Lozenges Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Nicotine Gums and Lozenges Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Nicotine Gums and Lozenges Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Nicotine Gums and Lozenges Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Nicotine Gums and Lozenges Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Nicotine Gums and Lozenges Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Nicotine Gums and Lozenges Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Nicotine Gums and Lozenges Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Nicotine Gums and Lozenges Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Nicotine Gums and Lozenges Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 75. Novartis Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Perrigo Company Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 79. Perrigo Company Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 80. Perrigo Company Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Perrigo Company Main Business
Table 82. Perrigo Company Latest Developments
Table 83. Pfizer Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 85. Pfizer Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Fertin Pharma Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 89. Fertin Pharma Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 90. Fertin Pharma Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Fertin Pharma Main Business
Table 92. Fertin Pharma Latest Developments
Table 93. Johnson & Johnson Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 95. Johnson & Johnson Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Cipla Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 100. Cipla Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Cipla Main Business
Table 102. Cipla Latest Developments
Table 103. Alkalon Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 104. Alkalon Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 105. Alkalon Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Alkalon Main Business
Table 107. Alkalon Latest Developments
Table 108. GSK Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 109. GSK Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 110. GSK Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. GSK Main Business
Table 112. GSK Latest Developments
Table 113. Reynolds American Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 114. Reynolds American Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 115. Reynolds American Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Reynolds American Main Business
Table 117. Reynolds American Latest Developments
Table 118. Dr. Reddy's Laboratories Basic Information, Nicotine Gums and Lozenges Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolios and Specifications
Table 120. Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Dr. Reddy's Laboratories Main Business
Table 122. Dr. Reddy's Laboratories Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nicotine Gums and Lozenges
Figure 2. Nicotine Gums and Lozenges Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotine Gums and Lozenges Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Nicotine Gums and Lozenges Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nicotine Gums and Lozenges Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nicotine Gums and Lozenges Sales Market Share by Country/Region (2024)
Figure 10. Nicotine Gums and Lozenges Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 2 mg/piece
Figure 12. Product Picture of 4 mg/piece
Figure 13. Product Picture of Other
Figure 14. Global Nicotine Gums and Lozenges Sales Market Share by Type in 2025
Figure 15. Global Nicotine Gums and Lozenges Revenue Market Share by Type (2020-2025)
Figure 16. Nicotine Gums and Lozenges Consumed in Withdrawal Clinics
Figure 17. Global Nicotine Gums and Lozenges Market: Withdrawal Clinics (2020-2025) & (K Units)
Figure 18. Nicotine Gums and Lozenges Consumed in Medical Practice
Figure 19. Global Nicotine Gums and Lozenges Market: Medical Practice (2020-2025) & (K Units)
Figure 20. Nicotine Gums and Lozenges Consumed in Individual Smokers
Figure 21. Global Nicotine Gums and Lozenges Market: Individual Smokers (2020-2025) & (K Units)
Figure 22. Nicotine Gums and Lozenges Consumed in Others
Figure 23. Global Nicotine Gums and Lozenges Market: Others (2020-2025) & (K Units)
Figure 24. Global Nicotine Gums and Lozenges Sale Market Share by Application (2024)
Figure 25. Global Nicotine Gums and Lozenges Revenue Market Share by Application in 2025
Figure 26. Nicotine Gums and Lozenges Sales by Company in 2025 (K Units)
Figure 27. Global Nicotine Gums and Lozenges Sales Market Share by Company in 2025
Figure 28. Nicotine Gums and Lozenges Revenue by Company in 2025 ($ millions)
Figure 29. Global Nicotine Gums and Lozenges Revenue Market Share by Company in 2025
Figure 30. Global Nicotine Gums and Lozenges Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Nicotine Gums and Lozenges Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Nicotine Gums and Lozenges Sales 2020-2025 (K Units)
Figure 33. Americas Nicotine Gums and Lozenges Revenue 2020-2025 ($ millions)
Figure 34. APAC Nicotine Gums and Lozenges Sales 2020-2025 (K Units)
Figure 35. APAC Nicotine Gums and Lozenges Revenue 2020-2025 ($ millions)
Figure 36. Europe Nicotine Gums and Lozenges Sales 2020-2025 (K Units)
Figure 37. Europe Nicotine Gums and Lozenges Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Nicotine Gums and Lozenges Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Nicotine Gums and Lozenges Revenue 2020-2025 ($ millions)
Figure 40. Americas Nicotine Gums and Lozenges Sales Market Share by Country in 2025
Figure 41. Americas Nicotine Gums and Lozenges Revenue Market Share by Country (2020-2025)
Figure 42. Americas Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
Figure 43. Americas Nicotine Gums and Lozenges Sales Market Share by Application (2020-2025)
Figure 44. United States Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Nicotine Gums and Lozenges Sales Market Share by Region in 2025
Figure 49. APAC Nicotine Gums and Lozenges Revenue Market Share by Region (2020-2025)
Figure 50. APAC Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
Figure 51. APAC Nicotine Gums and Lozenges Sales Market Share by Application (2020-2025)
Figure 52. China Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 56. India Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Nicotine Gums and Lozenges Sales Market Share by Country in 2025
Figure 60. Europe Nicotine Gums and Lozenges Revenue Market Share by Country (2020-2025)
Figure 61. Europe Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
Figure 62. Europe Nicotine Gums and Lozenges Sales Market Share by Application (2020-2025)
Figure 63. Germany Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 64. France Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Nicotine Gums and Lozenges Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Nicotine Gums and Lozenges Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Nicotine Gums and Lozenges Sales Market Share by Application (2020-2025)
Figure 71. Egypt Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Nicotine Gums and Lozenges Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Nicotine Gums and Lozenges in 2025
Figure 77. Manufacturing Process Analysis of Nicotine Gums and Lozenges
Figure 78. Industry Chain Structure of Nicotine Gums and Lozenges
Figure 79. Channels of Distribution
Figure 80. Global Nicotine Gums and Lozenges Sales Market Forecast by Region (2026-2031)
Figure 81. Global Nicotine Gums and Lozenges Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Nicotine Gums and Lozenges Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Nicotine Gums and Lozenges Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Nicotine Gums and Lozenges Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Nicotine Gums and Lozenges Revenue Market Share Forecast by Application (2026-2031)